Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," ...

AI is changing how cancer care decisions are made, empowering patients and doctors to make more personalized choices. For ...

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

The average age of men who get diagnosed is 67.

Prostate Cancer Survivor, Jerry McCormick, urges Black men 45 years and older to get screened as soon as possible, because early detection could save their life.

Prostate cancer has been one of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...

Panelists discuss how sharing personal experiences with diagnosis helps illuminate the critical questions patients should ask their care teams and the pivotal role oncologists play in guiding ...

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...

Add Yahoo as a preferred source to see more of our stories on Google. Warning issued as prostate cancer patients ‘missing out’ on life-extending care Some prostate cancer patients are “missing out” on ...

Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...